|
Aug 30
|
The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
|
|
Aug 29
|
Viking Therapeutics (VKTX) Fell Amid Rising Competition
|
|
Aug 29
|
Bioventus and Pool have been highlighted as Zacks Bull and Bear of the Day
|
|
Aug 28
|
Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference
|
|
Aug 28
|
Eli Lilly Launches Discounted Versions of Obesity Drug Zepbound
|
|
Aug 28
|
Why Viking Therapeutics Stock Price Moved Down 6% on Tuesday
|
|
Aug 28
|
Viking Therapeutics, Inc. (VKTX): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
|
|
Aug 27
|
Why Viking Therapeutics Stock Got Thrashed on Tuesday
|
|
Aug 27
|
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
|
|
Aug 27
|
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
|
|
Aug 26
|
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
|
|
Aug 26
|
Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?
|
|
Aug 25
|
Why Viking Therapeutics could be 'onto something pretty amazing'
|
|
Aug 3
|
3 Unstoppable Stocks to Buy in August
|
|
Aug 2
|
Viking Therapeutics (VKTX) Cooled Down After Strong Q1
|
|
Aug 2
|
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
|
|
Jul 29
|
Wall Street is still jittery on GLP-1s
|
|
Jul 29
|
The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
|
|
Jul 29
|
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
|
|
Jul 29
|
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
|